MSCs could increase the expression of SNHG7 in pancreatic cancer cells, which would promote the dryness and Folfirinox resistance of pancreatic cancer cells through the Notch1/Jagged1/Hes-1 signaling pathway (128). Here, HES1 is linked to pancreatic neoplasm.